The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chu Yu-waye since 2021.
This trader's CIK number is 1854586.
At the time of last reporting, Chu Yu-waye was the Chief Medical Officer of Cytomx Therapeutics, Inc.. (stock ticker symbol CTMX).
Also see all insider trading activities at Cytomx Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | FATE | 0 | $0 | 2,532 | $16,584 | 0 | $0 |
| 2022 | FATE | 0 | $0 | 8,027 | $337,045 | 0 | $0 |
| 2021 | FATE | 0 | $0 | 10,775 | $665,136 | 7,500 | $122,400 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CTMX | 0 | $0 | 4,025 | $2,410 | 0 | $0 |
1. Fate Therapeutics Inc (FATE)
2. Cytomx Therapeutics, Inc. (CTMX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-18 | FATE | Sale | 2,532 | 6.55 | 16,584 |
| 2022-04-19 | FATE | Sale | 4,062 | 35.37 | 143,672 |
| 2022-01-11 | FATE | Sale | 3,965 | 48.77 | 193,373 |
| 2021-12-10 | FATE | Option Ex | 7,500 | 16.32 | 122,400 |
| 2021-12-10 | FATE | Sale | 7,500 | 52.42 | 393,180 |
| 2021-04-16 | FATE | Sale | 3,275 | 83.04 | 271,956 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-18 | CTMX | Sale | 4,025 | .60 | 2,410 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chu Yu-waye (Chief Medical Officer of Cytomx Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.